Metabolic syndrome and chronic vascular disease;Metabolisches Syndrom und chronische Gefasserkrankung

Internist

Volumn 37, Issue 7, 1996, Pages 687-697

  Haller, H ^a,b   Knoblauch, H ^a   Schuster, H ^a   Luft, F C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Franz Volhard Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CHRONIC DISEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; REVIEW; SYNDROME; VASCULAR DISEASE; ARTERIOSCLEROSIS; CELL DIVISION; EXTRACELLULAR MATRIX; GENETICS; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CELL DIVISION; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; MUSCLE, SMOOTH, VASCULAR; SYNDROME;

EID: 0029975715     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Dzau VJ, Gibbons GH (1988) Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 62: 30G-35G
2. Gordon D, Reidy MA, Benditt EP, Schwartz SM (1990) Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87: 4600-4604
3. Schwratz CJ, Valente AJ, Sprague EA (1993) A modern view of atherogenesis. Am J Cardiol 71: 21-29
4. Ross R (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804
5. Lüscher TF, Vanhoutte PM (Press; 1990) The endothelium: modulator of cardiovascular function. CRC, Boca Raton
6. Lüscher TF (1995) Hypertension and vascular diseases: molecular and cellular mechanisms. Schweiz Med Wochenschr 125: 270-282
7. Lüscher TF (1994) The endothelium in hypertension: bystander, target or mediator? J Hypertens [Suppl] 12:S105-116
8. Stewart DJ (1995) Clinical relevance of endothelial dysfunction in cardiovascular disorders. Agents Actions Suppl 45: 227-235
9. Vane JR (1994) The Croonian lecture, 1993. The endothelium: maestro of the blood circulation. Philos Trans R Soc Lond B Biol Sci 343: 225-246
10. Heistad DD, Baumbach GL, Faraci FM, Armstrong ML (1995) Sick vessel syndrome: vascular changes in hypertension and atherosclerosis. J Hum Hypertens 9: 449-453
11. Simionescu M, Simionescu N (1986) Functions of the endothelial cell surface. Annu Rev Physiol 48: 279-304
12. Springer TA (1990) The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 6: 359-402
13. DiCorleto PE, Chisolm GM (1986) Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res 25: 3655-3374
14. Lum H, Malik AB (1994) Regulation of vascular endothelial barrier function. Am J Physiol 267:L223-L241
15. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet S 997-1000
16. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF (1992) Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 70: 1191-1197
17. Weisser B, Locher R, Mengden T, Sachinidis A, Vetter W (1991) Oxidation of low-density lipoprotein increases vasoconstriction in vitro. J Hypertens [Suppl] 9:S 172-173
18. Giugliano D, Ceriello A, Paolisso G (1995) Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44: 363-368
19. Mehta JL, Nicolini FA, Donnelly WH, Nichols WW (1992) Platelet-leukocyte-endothelial interactions in coronary artery disease. Am J Cardiol 69: 8B-13B
20. Richardson M, Hadcock SJ, DeReske M, Cybulsky MI (1994) Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 14: 760-769
21. Haller H, Schaper D, Ziegler W, Kuhlmann M, Luft FC (1995) LDL induces surface expression of vascular adhesion molecule (VCAM) on endothelial cells via activation of protein kinase C. Hypertension 25: 511-516
22. Lüscher TF, Noll G (1994) Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol [Suppl 3]:S16-26
23. Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86: 75
24. Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92: 652-662
25. Hayashi T, Ishikawa T, Naito M et al (1991) Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms. Functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators. Atherosclerosis 87: 23-38
26. Lorenzi M, Cagliero E (1991) Pathobiology of endothelial and other vascular cells in diabetes mellitus; call for data. Diabetes 40: 653-659
27. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463
28. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus [see comments]. Circulation 88: 2510-2516
29. Taylor PD, Graves JE, Poston L (1995) Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci Colch 88: 519-524
30. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics. Thromb Res 26: 359-370
31. Yamouchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H (1990) Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 267: 16-18
32. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306
33. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R (1995) Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18: 1-9
34. Sander B, Larsen M, Engler C, Lund Andersen H, Parving HH (1994) Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol Copenh 72: 553-559
35. Hempel A, Heintze U, Maaß C, Lindschau C, Dietz R, Luft FC, Haller H (in press) High glucose concentrations increase endothelial cell. Permeability via activation of protein kinase C-α. J Clin Invest
36. Gilcrease MZ, Hoover RL (1991) Examination of monocyte adherence to endothelium under hyperglycemic conditions. Am J Pathol 139: 1089-1097
37. Cagliero E, Roth T, Roy S, Lorenzi M (1991) Characteristics and mechanisms of high-glucose-induced over expression of basement membrane components in cultured human endothelial cells. Diabetes 40: 102-110
38. Roy S, Sala R, Cagliero E, Lorenzi M (1990) Over expression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 87: 404-408
39. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321
40. Vlassara H, Brownlee M, Monogue K, Dinarello CA, Pasagian A (1988) Cachetin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548
41. Stout RW, Bierman EL, Ross R (1975) Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 36: 319-327
42. King GL, Goodman AD, Buzney S, Boses A, Kahn CR (1985) Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75: 1028-1036
43. Capron J, Jarnet J, Kazandjian S, Housset E (1986) Growth-promoting effects of diabetes and insulin on arteries: an in vivo study of rat aorta. Diabetes 35: 973
44. Stout RW (1990) Insulin and atheroma. 20-yr perspective. Diabetes Care 13: 631-654
45. Vanhoutte PM, Boulanger CM (1995) Endothelium-dependent responses in hypertension. Hypertens Res 18: 87-98
46. van Zwieten PA, Safar M, Laurent S, Pfaffendorf M, Hendriks MG, Bruning TA (1995) New insights into the role of endothelial dysfunction in hypertension [editorial]. J Hypertens 13: 713-647
47. Taddei S, Virdis A, Mattei P et al (1995) Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91: 1981-1987
48. Deng LY, Li JS, Schiffrin EL (1995) Endothelium-dependcnt relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci Colch 88: 611-622
49. Antony I, Lerebours G, Nitenberg A (1995) Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation 91: 1624-1628
50. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO (1995) Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91: 1732-1738
51. Pedrinelli R, Giampietro O, Carmassi F et al (1994) Microalbuminuria and endothelial dysfunction in essential hypertension [see comments]. Lancet 344: 14
52. Nag S (1994) Cerebral endothelial mechanisms in increased permeability in chronic hypertension. Adv Exp Med Biol 331: 263-266
53. McCarron RM, Wang I, Siren AL, Spatz M, Hallenbeck JM (1994) Monocyte adhesion to cerebromicrovascular endothelial cells derived from hypertensive and normotensive rats. Am J Physiol 267: H2491-2497
54. McCarron RM, Wang L, Siren AL, Spatz M, Hallenbeck JM (1994) Adhesion molecules on normotensive and hypertensive rat brain endothelial cells. Proc Soc Exp Biol Med 205: 257-262
55. Suematsu M, Suzuki H, Tamatani T et al (1995) Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J Clin Invest 96: 2009-2016
56. Kesaniemi YA, Lilja M, Kervinen K, Rantala A (1992) Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med 24: 461-464
57. Schmickel R (1986) Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr 109: 231-241
58. Rossi GP, Pavan E, Pessina AC (1994) Role of genetic, humoral, and endothelial factors in hypertension-induced atherosclerosis. J Cardiovasc Pharmacol 23[Suppl 5]:S75-84
59. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F (1995) Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91: 96-102
60. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 1 Iβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265
61. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Click S, Milora RV, Kindling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the β subunits of the epithelial sodium channel. Cell 79: 407-414
62. Grim CE, Luft FC, Miller JZ, Rose RJ, Christian JC, Weinberger MH (1980) An approach to the evaluation of genetic influences on factors that regulate areterial blood pressure in man. Hypertension 2:1-34-42
63. Liddle GW, Bledsoe T, Coppage WS (1963) A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Phys 76: 199-213
64. Schuster H, Wienker T, Bilginturan N, Toka O, Haller H, Luft FC (1996) Severe autosomal dominant hypertension and brachydactyly: clinical characterization ot a unique kindred from Turkey. Nature Gen 13: 98-100
65. Caulfied M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL (1994) Linkage of angiotensinogen gene to essential hypertension. N Engl J Med 330: 1629-1633
66. Kurtz TW, Spence MA (1993) Genetics of essential hypertension. Am J Med 94: 77-80
67. Kotanko P, Hoglinger O, Skrabal F (1992) Beta 2-adrenoceptor density in fibroblast culture correlates with human NaCl sensitivity. Am J Physiol 263: C623-627
68. Ghosh S, Schork N (1996) Genetic analysis of NlDDM. The study of quantitative traits. Diabetes 45: 1-14
69. Elbein SC et al (1995) Linkage analysis of 19 candidate regions for insulin resistance in familial NlDDM. Diabetes 44: 1259-1265
70. Kan M et al (1995) Frequency of mutations of the insulin receptor gene in Japanese patients with NIDDM. Diabetes 44: 1081-1086
71. Brunetti A et al (1996) Human diabetes associated with detects in nuclear regulatory proteins for the insulin receptor gene. J Clin Invest 97: 258-262
72. Clausen J et al (1995) Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346: 397-402
73. Walston J et al (1995) Time of onset of the non-insulin dependent diabetes mellitus and genetic variation in the β3-adrenoreceptor gene. N Engl J Med 333: 343-347
74. Widen E et al (1995) Association of a polymorphism in the β3-adrenoreceptor gene with features of the insulin resistance syndrome in finns. N Engl J Med 333: 348-351
75. Zhang Y et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432 Blakemore A et al. (1996) Inlerleukin-1 receptor antagonist allele (ILRN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97: 369-374
76. Zhang Y et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432 Blakemore A et al. (1996) Inlerleukin-1 receptor antagonist allele (ILRN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97: 369-374
77. Vidal-Puig A et al (1995) Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln142-His Substitution. Diabetes 44: 340-334
78. Laakso M et al (1995) Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 44: 330
79. Echwald S et al (1945) Identification of tour amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectivness, and insulin sensivityì. Diabetes 44: 347-353
80. Yoshida H (1995) Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in japanese subjects. Diabetes 44: 389-393
81. Hager J et al (1995) A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genet 9: 299-304
82. Savitsky K et al (1995) A single ataxia teleangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749
83. Maddux B et al (1995) Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373: 448-451
84. Katsuya T et al (1995) Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose tolerance, hyperinsulinemia, and dyslipedemia. Arterioscler Thromb Vasc Biol 15: 779-782
85. Panahloo A et al (1995) The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 92: 3390-3393
86. Goldstein JL, Schrott HG, Hazzard WG, Bierman EL, Motulsky AG (1973) Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52: 1544-1568
87. Williams RR, Hunt SC, Wu LL, Hopkins PN, Hasstedt SJ, Schumacher MC, Stults BM, Kuida H (1990) Concordant dyslipidemia, hypertension and early coronary disease in Utah families. Klin Wochenschr 68 [Suppl 20]:53-59
88. Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, Barlow GK, Stults BM, Schumacher MC, Ludwig EH et al (1993) Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 6: 319S-327S
89. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR (1989) Apolipoprotein, low density lipoprotein subtraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9: 335-344
90. Cullen P, Farren B, Scott J, Farrall M (1994) Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 14: 1233-1249
91. Babirak SP, Brown BG, Brunzell JD (1992) Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 12: 1176-1183
92. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 92: 4462-4466
93. Nevin DN, Brunzell JD, Deeb SS (1994) The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb 14: 869-873
94. Reymer PW, Groenemeyer BE, Gagne E, Miao L, Appelman EE, Seidel JC, Kromhout D, Bijvoet SM, Oever van de K, Bruin T et al (1995) A frequently occurring mutation in the lipoprotein lipase gene (Asn291 Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 4: 1543
95. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman E (1994) Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Arteriscler Thromb 14: 1687-1694
96. Jarvik GP, Beaty TH, Gallagher PR, Coates PM, Conner JA (1993) Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia. Genet Epidemiol 10: 257-270
97. Houlston R, Lewis B, Humphries SE (1991) Polymorphisms of the apolipoprotein B and E genes and their possible roles in familial and non-familial combined hyperlipidaemia. Dis Markers 9: 319-325
98. Schmidt S (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Intern 47: 1176
99. Ko B et al (1995) An (A-C)n dinucleotide repeat polymorphic marker at the 5 ènd of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 44: 727-732
100. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F (1995) Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91: 96-102
101. Wenzel K, Hanke R, Speer A (1994) Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet 94: 452-453